Abridge

Enterprise ambient-AI scribe that converts clinician-patient conversations into structured EHR documentation and billing codes.

1. Core Product / Service

Abridge sells an ambient clinical-documentation platform. During a visit it listens to the doctor-patient conversation, transcribes it with speech recognition, and uses large language models to draft a structured clinical note. The differentiator is a "Contextual Reasoning Engine" that folds in patient history, clinician preferences, and hospital billing guidelines (e.g., CMS-HCC risk-adjustment models) so the output is not just a transcript but a coding-aware, reimbursement-ready note. [abridge.com/product, 2026-06-29]

The product is deeply embedded in Epic, the dominant US EHR. Abridge was the first ambient-AI vendor admitted to Epic's "Pals and Partners" program, giving it bidirectional data flow — reading chart context before the visit and writing structured documentation back afterward. The company has been expanding beyond the scribe into adjacent workflows: pre-visit prep, revenue-cycle / coding, and a broader "care intelligence" layer pitched around its Series E. [statnews.com 2025-08-29; abridge.com/blog/series-e, 2026-06-29]

2. Target Users & Pain Points

Abridge is enterprise-only: solo and small-group practices cannot buy it directly — it requires an institutional contract with a health system. Customers are large hospital systems and academic medical centers (Mayo Clinic, Johns Hopkins, Duke Health, Kaiser Permanente, the VA, and 250+ others). The pain solved is physician documentation burden and burnout: surveyed clinicians reported reduced documentation load, and the company cites time savings of roughly two hours per day for users. [research.contrary.com; abridge.com, 2026-06-29]

3. Competitive Landscape

Abridge differentiates on enterprise depth (Epic-native integration), coding/revenue-cycle accuracy, and brand: it won Best in KLAS for Ambient AI in both 2025 and 2026, the only vendor to do so twice. [deepcura.com; statnews.com, 2026-06-29]

4. Unique Observations

• The defining risk is that Abridge sits on top of Epic while Epic ships its own native scribe ("Art"). Abridge's bet is that being the deepest third-party partner plus its coding/revenue-cycle layer outruns a good-enough first-party feature. The CEO publicly downplaying Epic's launch is itself a signal of how load-bearing that question is. [statnews.com 2025-08-29]
• Founder-market fit is unusually tight: a practicing cardiologist who was previously a UPMC investor and funded his own co-founder's research. That UPMC lineage shows up in the cap table (UPMC Enterprises seeded the company).
• The strategic pivot from "scribe" to "care intelligence" / revenue cycle mirrors how openevidence and commure are each trying to become the broader clinical-AI platform rather than a single point tool — point solutions in healthcare AI are racing to widen before the EHRs commoditize them.

5. Financials / Funding

• Total raised (primary equity): $1.07B
• Latest valuation: $5.3B

6. People & Relationships

• Founders / key people: Shiv Rao (CEO), a practicing cardiologist and former UPMC investor; co-founder Zachary Lipton, a Carnegie Mellon ML professor. Founded 2018 in Pittsburgh. [research.contrary.com, 2026-06-29]
• Notable investors: Andreessen Horowitz (a16z, Series E lead), Lightspeed, Redpoint, IVP, Spark Capital, Union Square Ventures, UPMC Enterprises, Elad Gil, Khosla Ventures. [abridge.com/blog/series-e, 2026-06-29]
• Partners: Epic (first "Pal" ambient partner); deployed at Mayo Clinic, Johns Hopkins, Kaiser Permanente, Duke Health, the VA, 250+ health systems.
• Competitors: Nuance/Microsoft DAX, Epic "Art for Clinicians", ambience-healthcare, Suki, Nabla, DeepScribe, Augmedix.